Dow Up0.08% Nasdaq Down0.30%

Rexahn Pharmaceuticals, Inc. (RNN)

-NYSE MKT
0.71 Down 0.05(6.99%) Sep 19, 4:00PM EDT
|After Hours : 0.72 Up 0.01 (1.85%) Sep 19, 5:16PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue -   -   -   -  
Cost of Revenue -   -   -   -  
Gross Profit -   -   -   -  
Operating Expenses
Research Development1,701  1,272  994  781  
Selling General and Administrative1,798  1,485  1,329  1,033  
Non Recurring -   -   -   -  
Others10  9  9  10  
Total Operating Expenses -   -   -   -  
Operating Income or Loss (3,509) (2,766) (2,332) (1,824)
Income from Continuing Operations
Total Other Income/Expenses Net3,703  (11,834)(387)(317)
Earnings Before Interest And Taxes194  (14,600)(2,720)(2,141)
Interest Expense -   -   -   -  
Income Before Tax194  (14,600)(2,720)(2,141)
Income Tax Expense -   -   -   -  
Minority Interest -   -   -   -  
Net Income From Continuing Ops194  (14,600)(2,720)(2,141)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 194   (14,600) (2,720) (2,141)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 194   (14,600) (2,720) (2,141)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.